<DOC>
	<DOCNO>NCT00480896</DOCNO>
	<brief_summary>A long-term 0.03 % tacrolimus ointment base regimen comprise 6 week initial twice daily treatment subsequent twice weekly prophylactic application effectively treat active lesion atopic dermatitis , prevent , delay , reduce flare .</brief_summary>
	<brief_title>Treatment Control Atopic Dermatitis With 0.03 % Tacrolimus Ointment</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Male female patient ethnic group Patient least 215 year old suffer mild severe atopic dermatitis ( Rajka/Langeland score least 3 ) Patient genetic epidermal barrier defect Netherton 's syndrome generalise erythroderma Patient clinically significant skin infection affect ( treat ) area</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Dermatitis , atopic</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Child</keyword>
	<keyword>treatment outcome</keyword>
</DOC>